Ligand Pharmaceuticals Incorporated
$5.33B- Market cap
- $5.69B
- Debt
- +$374.08M
- Cash
- −$733.52M
Capital structure 94% equity / 6% debt · EV / Revenue 19.90x · EV / EBITDA 33.29x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
LGND · current priceP/E 46.60x
$285.64Latest market snapshot
Implied fair value · at WTW's multiple
$126.2155.8% below market
6.13 LGND EPS (TTM)×20.59x WTW P/E=$126.21
Market $285.64Implied $126.21
WTW · current priceP/E 20.59x
$334.78Latest market snapshot
Implied fair value · at LGND's multiple
$757.67126.3% above market
16.26 WTW EPS (TTM)×46.60x LGND P/E=$757.67
Market $334.78Implied $757.67